John is 2N Pharma’s co-founder and CSO and brings broad management experience and a strong scientific background. He was previously director of research at Medigene AG. Next, he is co-founder of the clinical-stage vaccine company 2A Pharma. In addition to his duties at 2N Pharma, John is also Associate Professor and Head of the Molecular Pharmacology Department at Aalborg University, Denmark.
